Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen

Posted in News, World

Johnson & Johnson announces the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies. The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Pediatrics. Recruitment in the trial is underway, and the first volunteers have received their initial vaccine dose. Enrollment is expected to be completed by the end of January.

• Continue Reading

How Can We Encourage Participation in Clinical Trials?

Posted in Articles, News, World

Failed clinical trials come at a huge cost to their pharmaceutical sponsors. Many trial sites fail to enroll more than a single patient—up to 60% of oncology trials, according to Covance, for example. Yet they estimate it costs a sponsor $50,000 for a site start-up, with a loss of almost $2 billion between 2006-2010 from non-performing sites.

Did you know that only 3% of patients with cancer⁠ participate in clinical trials? Although we have an aging population and cancer rates increase with age, this dismal participation rate hasn’t budged in recent years. What factors are at play?

• Continue Reading